Immune regulation of multiple sclerosis.

[1]  R. Spang,et al.  T cells become licensed in the lung to enter the central nervous system , 2012, Nature.

[2]  H. Hartung,et al.  Animal models of multiple sclerosis—Potentials and limitations , 2010, Progress in Neurobiology.

[3]  B. Becher,et al.  Cytokine networks in multiple sclerosis: lost in translation , 2010, Current opinion in neurology.

[4]  S. Hallermann,et al.  Cytotoxic CD8+ T Cell–Neuron Interactions: Perforin-Dependent Electrical Silencing Precedes But Is Not Causally Linked to Neuronal Cell Death , 2009, The Journal of Neuroscience.

[5]  H. Wekerle,et al.  Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions , 2009, Nature.

[6]  M. Mori,et al.  Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system , 2009, Nature Medicine.

[7]  G. Krishnamoorthy,et al.  Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis , 2009, Nature Medicine.

[8]  S. Blystone,et al.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype , 2009, Laboratory Investigation.

[9]  H. Weiner,et al.  Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary , 2008, Nature Reviews Drug Discovery.

[10]  H. von Büdingen,et al.  Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin‐specific antibodies , 2008, European journal of immunology.

[11]  L. O’Neill.  Primer: Toll-like receptor signaling pathways—what do rheumatologists need to know? , 2008, Nature Clinical Practice Rheumatology.

[12]  O. Kämpe,et al.  Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis , 2008, European journal of immunology.

[13]  F. Zipp,et al.  Roles of the kallikrein/kinin system in the adaptive immune system. , 2008, International immunopharmacology.

[14]  Lorraine Lau,et al.  MMPs in the central nervous system: where the good guys go bad. , 2008, Seminars in cell & developmental biology.

[15]  S. Waxman.  Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status , 2008, Nature Clinical Practice Neurology.

[16]  G. Krishnamoorthy,et al.  Experimental models of spontaneous autoimmune disease in the central nervous system , 2007, Journal of Molecular Medicine.

[17]  R. Hohlfeld,et al.  Dual role of inflammation in CNS disease , 2007, Neurology.

[18]  F. Zipp,et al.  The role of TRAIL/TRAIL receptors in central nervous system pathology. , 2007, Frontiers in bioscience : a journal and virtual library.

[19]  F. Zipp,et al.  Neuronal damage in brain inflammation. , 2007, Archives of neurology.

[20]  K. Toyka,et al.  Kinetics and Organ Distribution of IL-17-Producing CD4 Cells in Proteolipid Protein 139–151 Peptide-Induced Experimental Autoimmune Encephalomyelitis of SJL Mice1 , 2007, The Journal of Immunology.

[21]  D. Fitzgerald,et al.  Cutting Edge: TLR3 Stimulation Suppresses Experimental Autoimmune Encephalomyelitis by Inducing Endogenous IFN-β1 , 2006, The Journal of Immunology.

[22]  Frauke Zipp,et al.  The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases , 2006, Trends in Neurosciences.

[23]  F. Zipp,et al.  Death Ligands and Autoimmune Demyelination , 2006, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[24]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[25]  R. Ransohoff.  EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis. , 2006, Trends in immunology.

[26]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[27]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[28]  B. Becher,et al.  Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. , 2006, The Journal of clinical investigation.

[29]  L. Steinman,et al.  Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. , 2005, Trends in immunology.

[30]  P. Moynagh.  TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. , 2005, Trends in immunology.

[31]  I. Bechmann,et al.  Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  C. Hunter.  New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions , 2005, Nature Reviews Immunology.

[33]  H. Hartung,et al.  Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis , 2005 .

[34]  G. Cheng,et al.  The host type I interferon response to viral and bacterial infections , 2005, Cell Research.

[35]  I. Bechmann,et al.  Neuronal Damage in Autoimmune Neuroinflammation Mediated by the Death Ligand TRAIL , 2005, Neuron.

[36]  L. Platanias.  Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.

[37]  Roland Martin,et al.  Immunology of multiple sclerosis. , 2005, Annual review of immunology.

[38]  S. Miller,et al.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis , 2005, Nature Medicine.

[39]  B. Becher,et al.  Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis , 2005, Nature Medicine.

[40]  B. Segal.  CNS chemokines, cytokines, and dendritic cells in autoimmune demyelination , 2005, Journal of the Neurological Sciences.

[41]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.

[42]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[43]  A. Rosenwald,et al.  BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma , 2005, The Journal of experimental medicine.

[44]  S. Wahl,et al.  Regulatory T cells and transcription factors: gatekeepers in allergic inflammation. , 2004, Current opinion in immunology.

[45]  Y. Kooyk,et al.  Modelling of multiple sclerosis: lessons learned in a non-human primate , 2004, The Lancet Neurology.

[46]  A. Uccelli,et al.  Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Roland Martin,et al.  Development of biomarkers in multiple sclerosis. , 2004, Brain : a journal of neurology.

[48]  B. Serafini,et al.  Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.

[49]  M. Duddy,et al.  Distinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation?1 , 2004, The Journal of Immunology.

[50]  F. Zipp,et al.  Direct Impact of T Cells on Neurons Revealed by Two-Photon Microscopy in Living Brain Tissue , 2004, The Journal of Neuroscience.

[51]  Chulhee Choi,et al.  Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses , 2004, Brain Research Reviews.

[52]  J. Antel,et al.  Vulnerability of Human Neurons to T Cell-Mediated Cytotoxicity1 , 2003, The Journal of Immunology.

[53]  W. Shearer,et al.  Basic and clinical immunology. , 2003, The Journal of allergy and clinical immunology.

[54]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[55]  H. Hartung,et al.  New concepts in the immunopathogenesis of multiple sclerosis , 2002, Nature Reviews Neuroscience.

[56]  B. Weinshenker,et al.  Plasma exchange for severe attacks of CNS demyelination: Predictors of response , 2002, Neurology.

[57]  B. Trapp,et al.  Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis , 2002, Journal of neuropathology and experimental neurology.

[58]  R. Ransohoff,et al.  Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges. , 2001, Archives of neurology.

[59]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[60]  Lawrence Steinman,et al.  Multiple sclerosis: a two-stage disease , 2001, Nature Immunology.

[61]  R. Gold,et al.  Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders , 2001, Journal of Neuroimmunology.

[62]  P. Villoslada,et al.  Immune Responses Against the Myelin/Oligodendrocyte Glycoprotein in Experimental Autoimmune Demyelination , 2001, Journal of Clinical Immunology.

[63]  R. Egan,et al.  Th2 cytokines and asthma — The role of interleukin-5 in allergic eosinophilic disease , 2001, Respiratory research.

[64]  L. Fugger.  Human autoimmunity genes in mice. , 2000, Current opinion in immunology.

[65]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[66]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[67]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[68]  J. Frank,et al.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand , 2000, Nature Medicine.

[69]  H. Lassmann,et al.  Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.

[70]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[71]  D. Kolson,et al.  Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis , 2000, Multiple sclerosis.

[72]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[73]  J. Cyster,et al.  Leukocyte migration: Scent of the T zone , 2000, Current Biology.

[74]  M. Weller,et al.  Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system. , 1999, Immunology today.

[75]  S. Hauser,et al.  Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen‐specific antibody mediation , 1999, Annals of neurology.

[76]  M. Shlomchik,et al.  A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus , 1999, The Journal of experimental medicine.

[77]  H. Reiber,et al.  The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis , 1998, Multiple sclerosis.

[78]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[79]  A. O’Garra,et al.  Cytokines induce the development of functionally heterogeneous T helper cell subsets. , 1998, Immunity.

[80]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[81]  Voon Wee Yong,et al.  Matrix metalloproteinases and diseases of the CNS , 1998, Trends in Neurosciences.

[82]  D. Gilden,et al.  Restricted use of VH4 Germline segments in an acute multiple sclerosis brain , 1998, Annals of neurology.

[83]  Hans Lassmann,et al.  T-cell apoptosis in autoimmune diseases: termination of inf lammation in the nervous system and other sites with specialized immune-defense mechanisms , 1997, Trends in Neurosciences.

[84]  M. Lambert,et al.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.

[85]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[86]  S. Chandler,et al.  Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview , 1997, Journal of Neuroimmunology.

[87]  C. Brosnan,et al.  Mechanisms of Immune Injury in Multiple Sclerosis , 1996, Brain pathology.

[88]  L. Steinman.  A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[89]  H. Neumann,et al.  Induction of MHC class I genes in neurons. , 1995, Science.

[90]  B. Durand,et al.  Regulation of MHC class II gene expression. , 1995, Immunobiology.

[91]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[92]  J. Antel,et al.  Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor , 1994, Annals of neurology.

[93]  H. Lassmann,et al.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.

[94]  C. Froelich.  Modulation of the autologous mixed lymphocyte reaction by β-endorphin , 1987, Journal of Neuroimmunology.

[95]  H. Lassmann,et al.  Cellular immune reactivity within the CNS , 1986, Trends in Neurosciences.

[96]  E. Anderson.  Hudson et al. , 1977 .

[97]  A. Pestronk,et al.  Myasthenia gravis: passive transfer from man to mouse , 1975, Science.

[98]  P. Y. Paterson.  TRANSFER OF ALLERGIC ENCEPHALOMYELITIS IN RATS BY MEANS OF LYMPH NODE CELLS , 1960, The Journal of experimental medicine.

[99]  E. Kabat,et al.  THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS , 1946, The Journal of experimental medicine.

[100]  S. Khoury,et al.  Immunopathogenesis of multiple sclerosis. , 2012, Clinical immunology.

[101]  M. Racke,et al.  Toll-like receptors in multiple sclerosis. , 2009, Current topics in microbiology and immunology.

[102]  J. Newcombe,et al.  Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. , 2006, Brain : a journal of neurology.

[103]  R. Medzhitov,et al.  Toll-like receptors: linking innate and adaptive immunity. , 2004, Microbes and infection.

[104]  U. Utz,et al.  Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. , 2003, Brain : a journal of neurology.

[105]  C. Mackay,et al.  Chemoattractant receptors and immune responses , 1999 .

[106]  D. Chao,et al.  BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.

[107]  B. Trapp,et al.  Chemokines and chemokine receptors in model neurological pathologies: molecular and immunocytochemical approaches. , 1997, Methods in enzymology.

[108]  H. Birkedal‐Hansen.  Proteolytic remodeling of extracellular matrix. , 1995, Current opinion in cell biology.

[109]  A. Lanzavecchia,et al.  Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. , 1990, Annual review of immunology.

[110]  I. Cohen,et al.  The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis , 1981, European journal of immunology.